Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment

Chronic and acute adenosine A 2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB 1 receptor activation

(2017) Francisco M. Mouro et al.   NEUROPHARMACOLOGY

Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol

(2017) Arnau Busquets-Garcia et al.   NEUROPSYCHOPHARMACOLOGY

Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum

(2017) Estefanía Moreno et al.   NEUROPSYCHOPHARMACOLOGY

Novel Object Recognition Test for the Investigation of Learning and Memory in Mice

(2017) Lindsay M. Lueptow   Jove-Journal of Visualized Experiments

Therapeutic Potential of Cannabinoids in Psychosis

(2016) F. Markus Leweke et al.   BIOLOGICAL PSYCHIATRY

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

(2016) Orrin Devinsky et al.   LANCET NEUROLOGY

Cannabidiol (CBD) and its analogs: a review of their effects on inflammation

(2015) Sumner Burstein   BIOORGANIC & MEDICINAL CHEMISTRY

Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

(2015) John M McPartland et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

(2015) R B Laprairie et al.   BRITISH JOURNAL OF PHARMACOLOGY

Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors

(2015) Valentina Chiodi et al.   JOURNAL OF NEUROCHEMISTRY

Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory

(2015) P Li et al.   MOLECULAR PSYCHIATRY

Basomedial amygdala mediates top-down control of anxiety and fear

(2015) Avishek Adhikari et al.   NATURE

Cannabidiol as a Potential Treatment for Anxiety Disorders

(2015) Esther M. Blessing et al.   Neurotherapeutics

Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats

(2014) V. Fernandez-Duenas et al.   Disease Models & Mechanisms

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

(2014) Orrin Devinsky et al.   EPILEPSIA

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

(2014) Attila Oláh et al.   JOURNAL OF CLINICAL INVESTIGATION

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

(2013) M. Mecha et al.   NEUROBIOLOGY OF DISEASE

Does Cannabidiol Protect Against Adverse Psychological Effects of THC?

(2013) Raymond J. M. Niesink et al.   Frontiers in Psychiatry

Adenosine A2A–cannabinoid CB1 receptor interaction: An integrative mechanism in striatal glutamatergic neurotransmission

(2012) Maria Teresa Tebano et al.   BRAIN RESEARCH

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

(2012) Javier Fernández-Ruiz et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

GPCR Heteromers and their Allosteric Receptor-Receptor Interactions

(2012) K. Fuxe et al.   CURRENT MEDICINAL CHEMISTRY

Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor

(2012) Alison Ribeiro et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum

(2011) Pablo Pandolfo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Striatal Pre- and Postsynaptic Profile of Adenosine A2A Receptor Antagonists

(2011) Marco Orru et al.   PLoS One

Adenosine-cannabinoid receptor interactions. Implications for striatal function

(2010) Sergi Ferré et al.   BRITISH JOURNAL OF PHARMACOLOGY

Recognition memory: Material, processes, and substrates

(2010) Malcolm W. Brown et al.   HIPPOCAMPUS

Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery

(2010) T. Kenakin et al.   PHARMACOLOGICAL REVIEWS

Plastic modifications induced by object recognition memory processing

(2010) J. R. Clarke et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metabotropic glutamate type 5, dopamine D2and adenosine A2areceptors form higher-order oligomers in living cells

(2009) Nuria Cabello et al.   JOURNAL OF NEUROCHEMISTRY

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling

(2009) Emma Puighermanal et al.   NATURE NEUROSCIENCE

The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors

(2009) A. Castillo et al.   NEUROBIOLOGY OF DISEASE

Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory

(2008) Julia R. Clarke et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Parallel striatal and hippocampal systems for landmarks and boundaries in spatial memory

(2008) C. F. Doeller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY